Changes in determination of bronchodilator response in patients diagnosed with asthma

<bold>Introduction:</bold> bronchodilator response is often used in the diagnosis of asthma. In 2005 Pellegrino et al1 published interpretation strategies for spirometry, bronchodilator response (BR) was defined as an increase of 12% in FEV1 and 200ml, based on the measured values. In 2021 an update was published by Stanojevic et al 2 defining BR as an increase of 10% of the predicted value. <bold>Methods:</bold> data were obtained from the database in a general hospital. 123 patients with a new diagnosis of asthma, who performed spirometry (pre and post medication, SABA) were included in the analysis. BR was calculated using Excel. A chi-square test was performed to define any statistical differences using SPSS (Version 28). <bold>Results:</bold> characteristics are shown in table 1. Using the 2005 definition 23 patients showed a BR, with the 2021 definition 24 patients demonstrated a response. Figure 1 shows the difference in response between both methods. The chi-square test showed no significant difference. <table-wrap><object-id>erj;64/suppl_68/PA3919/T1</object-id><object-id>T1</object-id><object-id>t1</object-id><table><colgroup><col></col><col></col><col></col></colgroup><tbody><tr><td></td><td><bold>Male (N = 45)</bold></td><td><bold>Female (N =78)</bold></td></tr><tr><td><bold>Age (y)</bold></td><td>52 (18)</td><td>50 (16)</td></tr><tr><td><bold>FEV1 pre (L)</bold></td><td>3,1 (0,8)</td><td>2,4 (0,7)</td></tr><tr><td><bold>FEV1 pre (%)</bold></td><td>85,7 (15,7)</td><td>87,7 (16,3)</td></tr><tr><td><bold>FEV1 post(L)</bold></td><td>3,4 (0,9)</td><td>2,6 (0,7)</td></tr><tr><td><bold>FEV1 post (%)</bold></td><td>92,4 (11,4)</td><td>94 (16,8)</td></tr><tr><td><bold>Change 2005 (%)</bold></td><td>8,3 (7,6)</td><td>7,7 (8,2)</td></tr><tr><td><bold>Change 2021 (%)</bold></td><td>6,7 (5,7)</td><td>6,3 (5,7)</td></tr></tbody></table></table-wrap> <fig><object-id>erj;64/suppl_68/PA3919/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig> <bold>Conclusion:</bold> Using the new cut-off values in the determination of BR resulted in minor differences of BR in comparison with the 2005 values.

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.pa3919
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Changes in determination of bronchodilator response in patients diagnosed with asthma

Martijn Cuijpers, Herman Jan Pennings, Ragnar Lunder, Veerle De Visser Van Pol
Asthma and respiratory diseases
article

Changes in determination of bronchodilator response in patients diagnosed with asthma

Martijn Cuijpers, Herman Jan Pennings, Ragnar Lunder, Veerle De Visser Van Pol
article en

Abstract

<bold>Introduction:</bold> bronchodilator response is often used in the diagnosis of asthma. In 2005 Pellegrino et al1 published interpretation strategies for spirometry, bronchodilator response (BR) was defined as an increase of 12% in FEV1 and 200ml, based on the measured values. In 2021 an update was published by Stanojevic et al 2 defining BR as an increase of 10% of the predicted value. <bold>Methods:</bold> data were obtained from the database in a general hospital. 123 patients with a new diagnosis of asthma, who performed spirometry (pre and post medication, SABA) were included in the analysis. BR was calculated using Excel. A chi-square test was performed to define any statistical differences using SPSS (Version 28). <bold>Results:</bold> characteristics are shown in table 1. Using the 2005 definition 23 patients showed a BR, with the 2021 definition 24 patients demonstrated a response. Figure 1 shows the difference in response between both methods. The chi-square test showed no significant difference. <table-wrap><object-id>erj;64/suppl_68/PA3919/T1</object-id><object-id>T1</object-id><object-id>t1</object-id><table><colgroup><col></col><col></col><col></col></colgroup><tbody><tr><td></td><td><bold>Male (N = 45)</bold></td><td><bold>Female (N =78)</bold></td></tr><tr><td><bold>Age (y)</bold></td><td>52 (18)</td><td>50 (16)</td></tr><tr><td><bold>FEV1 pre (L)</bold></td><td>3,1 (0,8)</td><td>2,4 (0,7)</td></tr><tr><td><bold>FEV1 pre (%)</bold></td><td>85,7 (15,7)</td><td>87,7 (16,3)</td></tr><tr><td><bold>FEV1 post(L)</bold></td><td>3,4 (0,9)</td><td>2,6 (0,7)</td></tr><tr><td><bold>FEV1 post (%)</bold></td><td>92,4 (11,4)</td><td>94 (16,8)</td></tr><tr><td><bold>Change 2005 (%)</bold></td><td>8,3 (7,6)</td><td>7,7 (8,2)</td></tr><tr><td><bold>Change 2021 (%)</bold></td><td>6,7 (5,7)</td><td>6,3 (5,7)</td></tr></tbody></table></table-wrap> <fig><object-id>erj;64/suppl_68/PA3919/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig> <bold>Conclusion:</bold> Using the new cut-off values in the determination of BR resulted in minor differences of BR in comparison with the 2005 values.

Laurentius Ziekenhuis (NL)
Openalex Percentile: Top 72%
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Changes in determination of bronchodilator response in patients diagnosed with asthma — Martijn Cuijpers, Herman Jan Pennings, et al. · (2024) | TGRS Research Map | TGRS